Literature DB >> 2777420

Therapeutically relevant differences in the pharmacokinetical and pharmaceutical behavior of ibuprofen lysinate as compared to ibuprofen acid.

G Geisslinger1, K Dietzel, H Bezler, B Nuernberg, K Brune.   

Abstract

The pharmacokinetic properties of ibuprofen p.o. given either as a lysine salt or as acid to eight young, healthy male volunteers was investigated. Ibuprofen lysinate, administered after overnight fasting, produced peak plasma concentrations significantly earlier and higher than ibuprofen acid. A similar difference was observed when the drugs were given following a standardized breakfast. Under these conditions the lat-time was significantly shorter for the lysine salt than for the acid. The pharmacokinetic differences are likely to result from the faster dissolution rate of ibuprofen lysinate. They indicate that the administration of ibuprofen as lysine salt before meals may be advantageous if rapid and reliable onset of pain relief is required.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2777420

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  12 in total

Review 1.  Clinical pharmacokinetics of ibuprofen. The first 30 years.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

2.  Simultaneous fitting of R- and S-ibuprofen plasma concentrations after oral administration of the racemate.

Authors:  J Lötsch; U Muth-Selbach; I Tegeder; K Brune; G Geisslinger
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

3.  Variability in the stereoselective disposition of ibuprofen in patients with rheumatoid arthritis.

Authors:  G Geisslinger; K P Stock; D Loew; G L Bach; K Brune
Journal:  Br J Clin Pharmacol       Date:  1993-06       Impact factor: 4.335

Review 4.  Ibuprofen: pharmacology, efficacy and safety.

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2009-11-21       Impact factor: 4.473

5.  Population pharmacokinetics of high dose ibuprofen in cystic fibrosis.

Authors:  I Arranz; A Martín-Suárez; J M Lanao; F Mora; C Vázquez; A Escribano; M Juste; J Mercader; E Ripoll
Journal:  Arch Dis Child       Date:  2003-12       Impact factor: 3.791

6.  Dose-related effects of ibuprofen on pain-related potentials.

Authors:  G Kobal; C Hummel; M Gruber; G Geisslinger; T Hummel
Journal:  Br J Clin Pharmacol       Date:  1994-05       Impact factor: 4.335

7.  Differential effects of dipyrone, ibuprofen, and paracetamol on experimentally induced pain in man.

Authors:  C Forster; W Magerl; A Beck; G Geisslinger; T Gall; K Brune; H O Handwerker
Journal:  Agents Actions       Date:  1992-01

Review 8.  Effects of food on pharmacokinetics of immediate release oral formulations of aspirin, dipyrone, paracetamol and NSAIDs - a systematic review.

Authors:  Robert Andrew Moore; Sheena Derry; Philip J Wiffen; Sebastian Straube
Journal:  Br J Clin Pharmacol       Date:  2015-07-06       Impact factor: 4.335

9.  Bioavailability of ibuprofen following oral administration of standard ibuprofen, sodium ibuprofen or ibuprofen acid incorporating poloxamer in healthy volunteers.

Authors:  Peter M Dewland; Sandie Reader; Phillip Berry
Journal:  BMC Clin Pharmacol       Date:  2009-12-04

10.  SCISSOR-Spinal Cord Injury Study on Small molecule-derived Rho inhibition: a clinical study protocol.

Authors:  Marcel A Kopp; Thomas Liebscher; Ralf Watzlawick; Peter Martus; Stefan Laufer; Christian Blex; Ralf Schindler; Gerhard J Jungehulsing; Sven Knüppel; Martin Kreutzträger; Axel Ekkernkamp; Ulrich Dirnagl; Stephen M Strittmatter; Andreas Niedeggen; Jan M Schwab
Journal:  BMJ Open       Date:  2016-07-26       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.